Evidence map›Paper›PMID 34713583›Full record

ArticleJournal of the International AIDS Society2021

HIV service delivery in the time of COVID-19: focus group discussions with key populations in India.

Rose Pollard, Usha Gopinath, Yeruva A Reddy, Bogam R Kumar, Parthasarathy Mugundu, Canjeevaram K Vasudevan, Aylur K Srikrishnan, Aditya Singh, Allison M McFall, Kenneth H Mayer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Rose PollardDivision of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-9563-0918
Usha GopinathYR Gaitonde Center for AIDS Research and Education, Chennai, India.
Yeruva A ReddyDivision of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Bogam R KumarYR Gaitonde Center for AIDS Research and Education, Chennai, India.
Parthasarathy MugunduDivision of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Canjeevaram K VasudevanYR Gaitonde Center for AIDS Research and Education, Chennai, India.
Aylur K SrikrishnanYR Gaitonde Center for AIDS Research and Education, Chennai, India.
Aditya SinghDivision of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Allison M McFallDepartment of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Kenneth H MayerDepartment of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-7460-733X
Shruti H MehtaDepartment of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Sunil S SolomonDivision of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins University · USYR Gaitonde Centre for AIDS Research and Education · INBeth Israel Deaconess Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere are limited data on the impact of COVID-19-associated disruptions and novel HIV service delivery strategies among key populations (KPs) in low- and middle-income countries. In March 2020, in response to COVID-19, the Government of India revised HIV service delivery policies to include community antiretroviral therapy (ART) distribution and multi-month dispensing (MMD) of ART for all people living with HIV (PLHIV).

methodsTo assess the acceptability of these adaptations and impact of the pandemic among KPs, we conducted focus groups in November-December 2020 with purposively sampled men who have sex with men (MSM), female sex workers (FSWs) and transgender women (TGW) in Telangana and Maharashtra. Seven discussions were conducted. Topics included HIV service access, risk behaviours, economic security and feedback to ensure service continuity. Inductive coding identified themes across topics.

resultsForty-four individuals aged 20-49 years participated in discussions (13 MSM; 16 FSW; and 15 TGW). Twenty-four participants self-identified as living with HIV. People not living with HIV reported challenges in accessing HIV antibody testing at hospitals due to travel restrictions and fear of contracting COVID-19. Participants accessed HIV antibody testing using transportation arranged by community-based organizations after lockdowns eased. PLHIV reported uninterrupted ART refills and generally consistent adherence; however, there were experiences of delayed CD4 and HIV RNA testing. Participants shared appreciation for MMD as it saved time, money, and reduced exposure to COVID-19. Participants expressed gratitude for home deliveries which enabled ART access, yet shared concerns about home-based services causing confidentiality breaches with family/neighbours. Participants voiced preferences for community-based service provision due to proximity, convenient hours, and welcoming environments compared to public hospitals. Other requests included support for income, employment, nutrient-rich food and more accessible mental health, HIV, and other health services.

conclusionsCOVID-19 restrictions had a greater impact on access to HIV antibody, CD4, and RNA testing services compared to ART access. High acceptance of MMD and community-based services support the continued role of differentiated service delivery models to improve KP access to HIV antibody, CD4, RNA testing services, convenient ART retrieval, and integrated services beyond HIV, which may be critical for survival and wellbeing.

Indexed as

COVID-19HIV InfectionsSexual and Gender MinoritiesSex WorkersCommunicable Disease ControlFemaleFocus GroupsHomosexuality, MaleHumansIndiaMaleSARS-CoV-2COVID-19DSDHIVIndiakey populations

Identifiers

PMID34713583
PMCPMC8554214
OpenAlexW3210797182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.